C O M M U N I C A T I O N S
Table 2. Catalytic Enantioselective Fluorination of â-Ketoesters
fluorinated compounds, and the availability of R-fluoro â-hydroxy-
or â-amino acid derivatives for drug design should be valuable in
medicinal studies. Further details and an extension of this work
will be reported in due course.
Acknowledgment. This work was supported in part by The
Sumitomo Foundation. We thank Dr. Takao Saito of Takasago
International Corporation for providing their chiral phosphine
ligands. We also thank Dr. Norio Shibata of Toyama Medical and
Pharmaceutical University for providing unpublished analytical data
for their fluorinated compound.
entry
ketoester
catalyst (X)
temp (°C)
time (h)
yield (%)
ee (%)
1a
2
3
4
5
3a
3b
3c
3d
3e
3f
2c (TfO)
2b (BF4)
2b (TfO)
2b (BF4)
2c (TfO)
2b (TfO)
2b (BF4)
1b (TfO)
20
-10
-20
20
20
20
18
20
36
40
72
42
20
48
90
91
85
92
49c
88
82
96
92
94
83b
91b
91
87
91
91
Supporting Information Available: Experimental details of the
determination of the absolute configuration of 4c and 4d, and the
transformation of 5 into 6 and 7, as well as spectroscopic characteriza-
tion of new compounds (PDF). This material is available free of charge
6
7d
8e
3b
3d
0
20
a i-PrOH was used instead of EtOH. b The absolute configuration was
determined to be R after the conversion. c Lower yield due to the volatility
of 4e. d 2b (1 mol %) was used. 2.5 M 3b. e 1-g scale.
References
(1) Visiting Scientist from Takasago International Corporation. Address: 1-4-
11 Nishi-Yawata, Hiratsuka, Kanagawa 254-0073, Japan.
(2) (a) Ojima, I.; McCarthy, J. R.; Welch, J. T.; Eds. Biomedical Frontiers
of Fluorine Chemistry; ACS Symposium Series 639; American Chemical
Society: Washington, 1996. (b) Banks, R. E., Smart, B. E., Tatlow, J.
C., Eds.; Organofluorine Chemistry: Principles and Commercial Ap-
plications; Plenum: New York, 1994.
Scheme 1. Conversion into â-Hydroxy and â-Amino Estersa
(3) (a) Ramachandran, P. V.; Ed. Asymmetric Fluoroorganic Chemistry:
Synthesis, Application, and Future Directions; ACS Symposium Series
746; American Chemical Society: Washington, DC, 2000. (b) Soloshonok,
V. A., Ed. Enantiocontrolled Synthesis of Fluoro-Organic Compounds.
Stereochemical Challenge and Biomedicinal Targets; Wiley: New York,
1999.
(4) (a) Differding, E.; Lang, R. E. Tetrahedron Lett. 1988, 29, 6087-6090.
(b) Davis, F. A.; Zhou, P.; Murphy, C. K.; Sundarababu, G.; Qi, H.; Han,
W.; Przeslawski, R. M.; Chen, B.-C.; Carroll, P. J. Org. Chem. 1998, 63,
2273-2280. (c) Liu, Z.; Shibata, N.; Takeuchi, Y. J. Org. Chem. 2000,
65, 7583-7587. (d) Shibata, N.; Suzuki, E.; Asahi, T.; Shiro, M. J. Am.
Chem. Soc. 2001, 123, 7001-7009. (e) Mohar, B.; Baudoux, J.; Plaque-
vent, J.-C.; Cahard, D. Angew. Chem., Int. Ed. 2001, 40, 4214-4216.
(5) (a) Iwaoka, T.; Murohashi, T.; Sato, M.; Kaneko, C. Tetrahedron
Asymmetry 1992, 3, 1025-1028. (b) Davis, F. A.; Kasu, P. V. N.
Tetrahedron Lett. 1998, 39, 6135-6138. (c) Enders, D.; Faure, S.; Potthoff,
M.; Runsink, J. Synthesis, 2001, 15, 2307-2319.
a Conditions: a. PhMe2SiH (3.0), TBAF (2.0), DMF, 0 °C, 10 min, 83%
(dr ) >95/5); b. Ph3SiH (3.0), TFA, rt, 3 h, 75% (dr ) >95/5); c. Ph3P
(1.5), DEAD (1.5), DPPA (1.2), THF, rt, 2 h, 79% from syn-6, 73% from
anti-6; d. Pd/C, H2, (Boc)2O, MeOH, 1 h, 80% for anti-7, 57% for syn-7.
ee). In these reactions, we found that 2b and 2c were effective
catalysts, and various substrates were selectively fluorinated by
employing either of these two catalysts according to the nature of
the â-ketoester.
The absolute configurations of the products 4c and 4d were
determined to be R after conversion into a known compound.11 This
selectivity was in accord with the prediction based on the structure
of the square-planar chiral Pd enolate.9,11
Because â-hydroxy or â-amino acids are one of the fundamental
units in various natural or unnatural compounds, their R-fluorinated
derivatives are of particular interest.14 Therefore, we next turned
our attention to the transformation of the products (Scheme 1). We
found that the methyl ester 511 corresponding to 4d was converted
to both diastereomers of the R-fluoro â-hydroxy ester 6 in a highly
diastereoselective manner by simply changing the reducing condi-
tions.15 These compounds were subjected to azidation with inversion
of configuration. Reduction of the azide group, followed by
protection of the amino group, afforded the R-fluoro â-amino ester
7 in good yields.
In conclusion, we have developed a highly efficient catalytic
enantioselective fluorination of various â-keotesters with excellent
enantioselectivity (83-94% ee). It is environmentally advantageous
that this reaction proceeds well in alcoholic solvents, in particular,
EtOH, and is not sensitive to water. In addition, the transformation
of the product into both diastereomers of R-fluoro â-hydroxy- and
â-amino acid derivatives was successfully demonstrated. This report
provides a new method for the synthesis of optically active
(6) (a) Hintermann, L.; Togni, A. Angew. Chem., Int. Ed. 2000, 39, 4359-
4362. (b) Piana, S.; Devillers, I.; Togni, A.; Rothlisberger, U. Angew.
Chem., Int. Ed. 2002, 41, 979-982.
(7) Kim, D. Y.; Park, E. J. Org. Lett. 2002, 4, 545-547.
(8) Denis, A.; Bretin, F.; Fromentin, C.; Bonnet, A.; Piltan, G.; Bonnefoy,
A.; Agouridas, C. Bio. Med. Chem. Lett. 2000, 10, 2019-2022.
(9) Hamashima, Y.; Hotta, D.; Sodeoka, M. J. Am. Chem. Soc. 2002, 124,
11240-11241.
(10) In contrast, no reaction was observed in THF using salt-type fluorine
sources such as Selectfluor and N-fluoro-4-methylpyridinium-2-sulfonate.
(11) See Supporting Information.
(12) In the case of the Michael reaction, no reaction occurred with Pd complex
2. The addition of TfOH, which promoted the reaction as an activator of
the enone, was necessary. See ref 9.
(13) General Procedure: To a solution of the chiral palladium complex 2 (5
µmol) in EtOH (0.2 mL) was added â-ketoester (0.2 mmol) at room
temperature. At the temperature indicated in Table 2, NFSI (95 mg, 0.3
mmol) was added, and the resulting suspension was stirred for the time
given in Table 2. After the completion of the reaction (TLC), saturated
NH4Cl was added for quenching. Extraction with Et2O, followed by flash
column chromatography on SiO2 (hexane/Et2O ) 10/1) gave the pure
product.
(14) Recently, the effects of the stereochemistry of the carbon-fluorine bond
on the biological activity of HIV protease inhibitor, indinavir, have been
described. See: (a) Myers, A. G.; Barbay, J. K.; Zhong, B. J. Am. Chem.
Soc. 2001, 123, 7207-7219. In addition, â-amino acids are reported to
show a unique protease-resistant character as components of peptidomi-
metics. The availability of R-fluorinated derivatives will facilitate studies
in this field. See: (b) Cheng, R. P.; Gellman, S. H.; DeGrado, W. F.
Chem. ReV. 2001, 101, 3219-3232. (c) Gademann, K.; Ernst, M.; Hoyer,
D.; Seebach, D. Angew. Chem., Int. Ed. 1999, 38, 1223-1226.
(15) The relative configurations of products were tentatively assigned by
analogy with the results obtained in the literature. See: Kitazume, T.;
Kobayashi, T.; Yamamoto, T.; Yamazaki, T. J. Org. Chem. 1987, 52,
3218-3223.
JA028464F
9
J. AM. CHEM. SOC. VOL. 124, NO. 49, 2002 14531